title: Prevalence of abnormal levels of serum tumour markers in elderly people.
abstract: The study was conducted to evaluate the prevalence of abnormal levels of several serum tumour markers in an institutionalized elderly population. Serum tumour markers assay of carcinoembryonic antigen (CEA), the carbohydrate antigens CA 19-9, CA 72-4 and CA 15-3 (Enzymun-test, Boehringer Mannheim GmbH Diagnostic), alpha-fetoprotein (AFP) and prostate specific antigen (PSA) (Abbot Diagnostic Division) were performed in 228 unselected, institutionalized elderly subjects, whose mean age (SD) was 82.4 (5. 79) range (66-99 years). Patients with acute or neoplastic diseases were excluded from the study. The serum markers were also measured in 52 healthy young adults (controls). Using the established threshold values, 92 subjects (40%) were found to have at least one elevated marker. PSA was elevated in 33%, CA 19-9 in 16%, CEA in 11. 5%, CA 15-3 in 11%, CA 72-4 in 8% and AFP in 3%. We found a significant difference in the serum levels between the two groups for CEA, CA 19-9. CA 15-3, and PSA (p < 0.0001). Healthy aged people appear to have an elevated prevalence of elevated levels of serum tumour markers. The results suggest that apart from PSA, elevated antigen levels in elderly subjects are related to the ageing process itself rather than to occult pathology.
authors.affiliation: Hospital del Insalud, Soria, Spain.
authors.forename: L A
authors.initials: LA
authors.lastname: Lopez
authors.forename: V
authors.initials: V
authors.lastname: Del Villar
authors.forename: M
authors.initials: M
authors.lastname: Ulla
authors.forename: F
authors.initials: F
authors.lastname: Fernandez
authors.forename: L A
authors.initials: LA
authors.lastname: Fernandez
authors.forename: I
authors.initials: I
authors.lastname: Santos
authors.forename: L
authors.initials: L
authors.lastname: Rabadan
authors.forename: M
authors.initials: M
authors.lastname: Gutierrez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000097:blood; D005260:Female; D005293:Ferritins / Q000097:blood; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D018396:Mucin-1 / Q000097:blood; D015995:Prevalence; D017430:Prostate-Specific Antigen / Q000097:blood; D012016:Reference Values; D000509:alpha-Fetoproteins / Q000378:metabolism
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; C083825:CA-72-4 antigen; D002272:Carcinoembryonic Antigen; D018396:Mucin-1; D000509:alpha-Fetoproteins; D005293:Ferritins; D017430:Prostate-Specific Antigen